Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016.

DKK 2016

24–27 February 2016 | Berlin, Germany

DKK 2016

24–27 February 2016 | Berlin, Germany

The German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016.

Subtypes of pediatric acute lymphoblastic leukemia 2:15
Subtypes of pediatric acute lymphoblastic leukemia
Martin Schrappe • 25 Feb 2016
Acute myeloid leukemia in children: Biology, diagnostics and treatment 3:43
Acute myeloid leukemia in children: Biology, diagnostics and treatment
Dirk Reinhardt • 25 Feb 2016
Incorporating monoclonal antibodies in the treatment algorithm of multiple myeloma 2:12
Incorporating monoclonal antibodies in the treatment algorithm of multiple myeloma
Christof Scheid • 25 Feb 2016
Prolonging remission and survival in multiple myeloma 1:47
Prolonging remission and survival in multiple myeloma
Christof Scheid • 25 Feb 2016
Personalised medicine in CLL: Redefining the treatment approach 3:41
Personalised medicine in CLL: Redefining the treatment approach
Michael Hallek • 25 Feb 2016
Achieving a definitive treatment for chronic lymphocytic leukemia 1:43
Achieving a definitive treatment for chronic lymphocytic leukemia
Michael Hallek • 25 Feb 2016
iwCLL 2017 | International Workshop on Chronic Lymphocytic Leukemia 1:54
iwCLL 2017 | International Workshop on Chronic Lymphocytic Leukemia
Michael Hallek • 25 Feb 2016
Factors that contribute to treatment decisions in acute myeloid leukemia 1:25
Factors that contribute to treatment decisions in acute myeloid leukemia
Christoph Röllig • 25 Feb 2016
Clinical advances in acute myeloid leukemia 2:25
Clinical advances in acute myeloid leukemia
Christoph Röllig • 25 Feb 2016
Chemotherapy-free management of indolent lymphoma 3:37
Chemotherapy-free management of indolent lymphoma
Wolfgang Hiddemann • 25 Feb 2016
Current treatment of the leukemias 3:20
Current treatment of the leukemias
Rüdiger Hehlmann • 25 Feb 2016
The balance between drug affordability and cancer care 3:36
The balance between drug affordability and cancer care
Rüdiger Hehlmann • 25 Feb 2016
Precision medicine for lymphoma: Defining the individual patient 2:15
Precision medicine for lymphoma: Defining the individual patient
Lorenz Trümper • 25 Feb 2016
Treatment of lymphoma: Overview of the continued progress 5:02
Treatment of lymphoma: Overview of the continued progress
Lorenz Trümper • 25 Feb 2016

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals